166 related articles for article (PubMed ID: 15578716)
21. Overexpression of anti-apoptotic Mcl-1 in testicular germ cell tumours.
Sano M; Nakanishi Y; Yagasaki H; Honma T; Oinuma T; Obana Y; Suzuki A; Nemoto N
Histopathology; 2005 May; 46(5):532-9. PubMed ID: 15842635
[TBL] [Abstract][Full Text] [Related]
22. Mcl-1 overexpression in hepatocellular carcinoma: a potential target for antisense therapy.
Sieghart W; Losert D; Strommer S; Cejka D; Schmid K; Rasoul-Rockenschaub S; Bodingbauer M; Crevenna R; Monia BP; Peck-Radosavljevic M; Wacheck V
J Hepatol; 2006 Jan; 44(1):151-7. PubMed ID: 16289418
[TBL] [Abstract][Full Text] [Related]
23. Loss of 14-3-3 sigma protein expression and presence of human papillomavirus type 16 E6 in oral squamous cell carcinoma.
Bhawal UK; Sugiyama M; Nomura Y; Kuniyasu H; Tsukinoki K
Arch Otolaryngol Head Neck Surg; 2008 Oct; 134(10):1055-9. PubMed ID: 18936350
[TBL] [Abstract][Full Text] [Related]
24. In situ expression patterns of melanoma inhibitory activity 2 in healthy and diseased livers.
Hellerbrand C; Bataille F; Schlegel J; Hartmann A; Mühlbauer M; Schölmerich J; Büttner R; Hofstädter F; Bosserhoff AK
Liver Int; 2005 Apr; 25(2):357-66. PubMed ID: 15780062
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical expression of the proliferative marker Ki67 in hydatidiform moles and its diagnostic value in the progression to gestational trophoblastic neoplasia.
Hasanzadeh M; Sharifi N; Esmaieli H; Daloee MS; Tabari A
J Obstet Gynaecol Res; 2013 Feb; 39(2):572-7. PubMed ID: 22925155
[TBL] [Abstract][Full Text] [Related]
26. Apoptotic activity in gestational trophoblastic disease correlates with clinical outcome: assessment by the caspase-related M30 CytoDeath antibody.
Chiu PM; Ngan YS; Khoo US; Cheung AN
Histopathology; 2001 Mar; 38(3):243-9. PubMed ID: 11260306
[TBL] [Abstract][Full Text] [Related]
27. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
[TBL] [Abstract][Full Text] [Related]
28. Amplification of c-erbB2 oncogene: a major prognostic indicator in uterine serous papillary carcinoma.
Santin AD; Bellone S; Van Stedum S; Bushen W; Palmieri M; Siegel ER; De Las Casas LE; Roman JJ; Burnett A; Pecorelli S
Cancer; 2005 Oct; 104(7):1391-7. PubMed ID: 16116605
[TBL] [Abstract][Full Text] [Related]
29. Expression and prognostic relevance of Mcl-1 in breast cancer.
O'Driscoll L; Cronin D; Kennedy SM; Purcell R; Linehan R; Glynn S; Larkin A; Scanlon K; McDermott EW; Hill AD; O'Higgins NJ; Parkinson M; Clynes M
Anticancer Res; 2004; 24(2A):473-82. PubMed ID: 15152946
[TBL] [Abstract][Full Text] [Related]
30. Effects of left ventricular volume overload on mitochondrial and death-receptor-mediated apoptotic pathways in the transition to heart failure.
Moorjani N; Westaby S; Narula J; Catarino PA; Brittin R; Kemp TJ; Narula N; Sugden PH
Am J Cardiol; 2009 May; 103(9):1261-8. PubMed ID: 19406269
[TBL] [Abstract][Full Text] [Related]
31. Telomerase activity in complete hydatidiform mole.
Sukcharoen N; Mutirangura A; Limpongsanurak S
J Reprod Med; 1999 May; 44(5):465-70. PubMed ID: 10360262
[TBL] [Abstract][Full Text] [Related]
32. P63 expression in gestational trophoblastic disease: correlation with proliferation and apoptotic dynamics.
Zhang HJ; Xue WC; Siu MK; Liao XY; Ngan HY; Cheung AN
Int J Gynecol Pathol; 2009 Mar; 28(2):172-8. PubMed ID: 19188816
[TBL] [Abstract][Full Text] [Related]
33. Nuclear factor-kappaB activation and differential expression of survivin and Bcl-2 in human grade 2-4 astrocytomas.
Angileri FF; Aguennouz M; Conti A; La Torre D; Cardali S; Crupi R; Tomasello C; Germanò A; Vita G; Tomasello F
Cancer; 2008 May; 112(10):2258-66. PubMed ID: 18327814
[TBL] [Abstract][Full Text] [Related]
34. Complete hydatidiform mole with retained maternal chromosomes 6 and 11.
McConnell TG; Norris-Kirby A; Hagenkord JM; Ronnett BM; Murphy KM
Am J Surg Pathol; 2009 Sep; 33(9):1409-15. PubMed ID: 19542869
[TBL] [Abstract][Full Text] [Related]
35. Comparative proteomic analysis between benign and malignant-transformed hydatidiform mole.
Ma L; Xiang Y; Zhao J; Feng F; Wan X
J Reprod Med; 2008 Aug; 53(8):623-8. PubMed ID: 18773628
[TBL] [Abstract][Full Text] [Related]
36. Influence of hydatidiform mole follow-up setting on postmolar gestational trophoblastic neoplasia outcomes: a cohort study.
Dantas PR; Maestá I; Cortés-Charry R; Growdon WB; Braga A; Rudge MV; Berkowitz RS
J Reprod Med; 2012; 57(7-8):305-9. PubMed ID: 22838246
[TBL] [Abstract][Full Text] [Related]
37. Methylation status and expression of E-cadherin and cadherin-11 in gestational trophoblastic diseases.
Xue WC; Feng HC; Tsao SW; Chan KY; Ngan HY; Chiu PM; Maccalman CD; Cheung AN
Int J Gynecol Cancer; 2003; 13(6):879-88. PubMed ID: 14675328
[TBL] [Abstract][Full Text] [Related]
38. p57(KIP2) immunohistochemical staining of gestational trophoblastic tumours does not identify the type of the causative pregnancy.
Sebire NJ; Rees HC; Peston D; Seckl MJ; Newlands ES; Fisher RA
Histopathology; 2004 Aug; 45(2):135-41. PubMed ID: 15279631
[TBL] [Abstract][Full Text] [Related]
39. Molecular genetic analyses of choriocarcinoma.
Zhao J; Xiang Y; Wan XR; Feng FZ; Cui QC; Yang XY
Placenta; 2009 Sep; 30(9):816-20. PubMed ID: 19647314
[TBL] [Abstract][Full Text] [Related]
40. Quantitative expression analysis and prognostic significance of the novel apoptosis-related gene BCL2L12 in colon cancer.
Kontos CK; Papadopoulos IN; Scorilas A
Biol Chem; 2008 Dec; 389(12):1467-75. PubMed ID: 18844453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
